Metastatic Esophagogastric Cancer (MSK, Cancer Discovery 2017)

Summary

Metastatic Esophagogastric Cancer (MSK, Cancer Discovery 2017) is a study catalogued by cBioPortal DataHub under the cancer-type code egc. EvidenceHelix groups it with esophagus and stomach studies.

Study description

Targeted sequencing of 341 samples from 305 metastatic esophagogastric cancer patients

Text as published in the source's study metadata.

Citation & PubMed

Janjigian et al. Cancer Discov 2017

Linked PubMed records: PMID 29122777

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

egc_msk_2017

Short name

EGC (MSK 2017)

Source cancer-type code

egc

Reference genome

not given

Source access groups

PUBLIC

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Janjigian et al. Cancer Discov 2017

• PubMed record 29122777 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Esophageal Cancer-TRAP Project (MSK, Lancet Oncol 2020)

  Targeted and WES recapture sequencing of tumor/normal samples from 37 Esophageal Cancer patients.

  Esophagus and stomachMSK studiesSource code egcPubMed 1

• Esophagogastric Cancer (MSK, Clin Cancer Res 2022)

  Targeted sequencing of 237 esophagogastric tumor/normal pairs via MSK-IMPACT platform.

  Esophagus and stomachMSK studiesSource code egcPubMed 1

• Esophagogastric Cancer (MSK, Clin Cancer Res 2023)

  Whole exome sequencing of 64 esophagogastric cancers and their matched normal samples.

  Esophagus and stomachMSK studiesSource code egcPubMed 1

• Esophageal Carcinoma (TCGA, Nature 2017)

  Whole exome sequencing of 559 esophageal and gastric carcinoma tumors with matched normals.

  Esophagus and stomachTCGA (other releases)Source code egcPubMed 1

• Gastric Adenocarcinoma (TMUCIH, PNAS 2015)

  Whole-exome sequencing of 78 Gastric Adenocarcinomas and their matched normal samples.

  Esophagus and stomachOther published and consortium studiesSource code egcPubMed 1

• Esophageal/Stomach Cancer (MSK, 2020)

  Targeted sequencing of 487 Esophageal/stomach cancer tumor-normal pairs via MSK-IMPACT.

  Esophagus and stomachMSK studiesSource code stomachPubMed 1

• Esophagogastric Cancer (MSK, J Natl Cancer Inst 2023)

  Targeted sequencing of 902 patients with early-onset and average-onset esophagogastric cancers and their matched normals via MSK-IMPACT.

  Esophagus and stomachMSK studiesSource code stomachPubMed 1

• Esophageal Adenocarcinoma (DFCI, Nat Genet 2013)

  Whole-exome sequencing of 149 tumor/normal pairs and whole-genome sequencing of 16 pairs from 149 esophageal adenocarcinoma patients.

  Esophagus and stomachOther published and consortium studiesSource code escaPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.